glp-1 study Therapy for Patients with Obesity Cardiovascular and mortality outcomes with
Description
Ethics declarations Competing interests J.F., R.H.Z
No direct interaction, but appetite stacking and CV monitoring are relevant
Poole, R
Eli Lillys orforglipron represents a breakthrough in this transition as the first oral small-molecule GLP-1RA to complete Phase 3 trials
